机构:[1]Department of Chinese Medicine, Naval Medical University, Shanghai 200433, People’s Republic of China [2]Department of Chinese Medicine Oncology, Changhai Hospital affiliated to Naval Medical University, Shanghai 200433, People’s Republic of China [3]Beijing University of Traditional Chinese Medicine, Beijing 100700, People’s Republic of China [4]Department of Integrated Chinese and Western Medicine & Geriatric Oncology, Peking University Cancer Hospital, Beijing 100142, People’s Republic of China [5]Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, People’s Republic of China 深圳市中医院深圳医学信息中心[6]Present Address: Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, 60 College Street, New Haven, CT 06520‑8034, USA [7]School of Medicine, Center for Biomedical Data Science, Yale University, 60 College Street, New Haven, CT 06520‑8034, USA [8]Yale Cancer Center, Yale University, 60 College Street, New Haven, CT 06520‑8034, USA
第一作者机构:[1]Department of Chinese Medicine, Naval Medical University, Shanghai 200433, People’s Republic of China [2]Department of Chinese Medicine Oncology, Changhai Hospital affiliated to Naval Medical University, Shanghai 200433, People’s Republic of China [5]Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, People’s Republic of China [6]Present Address: Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, 60 College Street, New Haven, CT 06520‑8034, USA [7]School of Medicine, Center for Biomedical Data Science, Yale University, 60 College Street, New Haven, CT 06520‑8034, USA [8]Yale Cancer Center, Yale University, 60 College Street, New Haven, CT 06520‑8034, USA
通讯作者:
通讯机构:[1]Department of Chinese Medicine, Naval Medical University, Shanghai 200433, People’s Republic of China [2]Department of Chinese Medicine Oncology, Changhai Hospital affiliated to Naval Medical University, Shanghai 200433, People’s Republic of China [5]Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, People’s Republic of China [6]Present Address: Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, 60 College Street, New Haven, CT 06520‑8034, USA [7]School of Medicine, Center for Biomedical Data Science, Yale University, 60 College Street, New Haven, CT 06520‑8034, USA [8]Yale Cancer Center, Yale University, 60 College Street, New Haven, CT 06520‑8034, USA
推荐引用方式(GB/T 7714):
Han Rui,Yang Hongxing,Li Ya,et al.Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer[J].MEDICAL ONCOLOGY.2022,39(12):doi:10.1007/s12032-022-01814-9.
APA:
Han Rui,Yang Hongxing,Li Ya,Ling Changquan&Lu Lingeng.(2022).Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer.MEDICAL ONCOLOGY,39,(12)
MLA:
Han Rui,et al."Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer".MEDICAL ONCOLOGY 39..12(2022)